Intec Pharma Ltd. (NASDAQ: NTEC) Starts Presentation at 30th Annual ROTH Conference
Intec Pharma (NASDAQ: NTEC) is a clinical-stage biopharmaceutical company that focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. Intec's product pipeline includes the Accordion Pill Carbidopa/Levodopa, or AP-CD/LD, which is being developed for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. The company’s pipeline also includes AP-CBD/THC, an Accordion Pill with cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”), which…







